logo image
search icon
Diagnostic Contract Manufacturing Market

Diagnostic Contract Manufacturing Market Size, Share & Trends Analysis Report By Device (In Vitro Diagnostic Devices (IVD Consumables, IVD Equipment), Diagnostic Imaging Devices (X-ray, CT scan, Ultrasound, MRI, Others), Other Devices), By Service (Device Development & Manufacturing, Quality Management, Packaging & Assembly), By Application, By Region, And By Segment Forecasts, 2024-2031.

Report ID : 2449 | Published : 2024-04-29 | Pages: 180 | Format: PDF/EXCEL

Diagnostic Contract Manufacturing Market Size is valued at USD 25.7 Bn in 2023 and is predicted to reach USD 57.9 Bn by the year 2031 at a 10.78% CAGR during the forecast period for 2024-2031.

Diagnostic Contract Manufacturing Market info

Diagnostic contract manufacturing is a vital element of the diagnostics supply chain, providing customized solutions that allow diagnostic organizations to allocate more resources towards product innovation and market growth, all the while capitalizing on specialized manufacturing proficiency. In the diagnostics industry, it is common practice to streamline procedures and tap into the expertise of particular manufacturers. There are several benefits of IVD contract manufacturing. 

Diagnostic companies can profit from efficient and cost-effective production while focusing on R&D, marketing, and other key skills by outsourcing to specialized manufacturers. Production costs, operational efficiency, and the time it takes to bring new diagnostic equipment to market might all be improved with this strategy. Companies can access global markets through contract manufacturers, who are already established, and save considerably by investing in infrastructure. Furthermore, innovations in in vitro diagnostics are driving the market forward.

However, the market growth is hampered by the technical issues criteria for the safety and health of the diagnostic contract manufacturing market and the product's inability to prevent fog in environments with dramatic temperature fluctuations or high diagnostic contract manufacturing because of issues with intellectual property and the complexity of customizing products. Intellectual property protection becomes more difficult when diagnostic contract businesses and contract manufacturers work together because of the sharing of confidential information and technology. A lack of open collaboration could affect IVD companies' desire to engage in outsourcing partnerships because there are worries regarding the safety of data and the possibility of unlawful exploitation of novel diagnostic technologies. The market for in-vitro diagnostics has been affected in different ways by the COVID-19 epidemic. Even though the pandemic immediately hampered research and laboratory operations, it ultimately brought attention to the need for RNA-based research and therapies.

Competitive Landscape

Some Major Key Players In The Diagnostic Contract Manufacturing Market:

  • Jabil Inc.
  • Flex Ltd.
  • Plexus Corp
  • Sanmina Corporation
  • TE Connectivity Ltd.
  • Celestica Inc.
  • Integer Holdings Corporation
  • Nipro Medical Corporation
  • Thermo Fisher Scientific
  • West Pharmaceutical Services, Inc.
  • Benchmark Electronics Inc.
  • Kimball Electronics Inc.
  • KMC Systems
  • Savyon Diagnostics
  • Nova Biomedical
  • Cenogenic Corporation
  • Cone Bioproducts
  • Avioq Inc.
  • Philips-Medisize Corporation
  • Invetech
  • Meridian Bioscience, Inc.
  • Nolato AB
  • Fujirebio
  • Sekisui
  • Prestige Diagnostics
  • Biokit
  • Other Market Players

Market Segmentation:

The diagnostic contract manufacturing market is segmented based on device, service and application. The Device segment comprises In Vitro Diagnostic Devices (IVD Consumables, IVD Equipment), Diagnostic Imaging Devices (X-ray, CT scan, Ultrasound, MRI, Others), and Other Devices. Whereas, By Service, the market is segmented as Device Development & Manufacturing, Quality Management, and Packaging & Assembly. The Application segment includes In Vitro Diagnostic Devices (Infectious Diseases, Diabetes, Oncology, Cardiology, Others), Diagnostic Imaging Devices (Cardiology, Neurology, Orthopedics, Oncology, Others), and Other Devices (Gastroenterology, Gynecology, Others).

Based On The Device, The In Vitro Diagnostic Devices Segment Is Accounted As A Major Contributor To The Diagnostic Contract Manufacturing Market 

The in vitro diagnostic devices diagnostic contract manufacturing market is expected to lead with a major global market share in 2023. In vitro diagnostic procedures involve the examination of a patient's blood or tissue samples. They help monitor the patient's vitals and are utilized for precise diagnostic testing of illnesses and other underlying conditions. Each patient's best course of treatment can be better determined with the help of these diagnostic tests. With the rise in both acute and chronic disorders continuing to rise, the in vitro diagnostics business is seeing rapid growth.

Quality Management Segment To Witness Growth At A Rapid Rate.

The quality management industry uses the bulk of acrylic acid ester usage because, with the support of a quality management system (QMS), customers may be confident that their needs will be fully addressed, if not surpassed. In order to optimize operations, reduce waste, and identify and eliminate process inefficiencies, a corporation should develop a quality management system, especially in countries like the US, Germany, the UK, China, and India.

In The Region, The North American Diagnostic Contract Manufacturing Market Holds A Significant Revenue Share.

The Asia Pacific diagnostic contract manufacturing market is expected to register the large market share in revenue in the near future. It can be attributed to increasing supportive government policies and a robust diagnostic system. In addition, North America is projected to grow rapidly in the global diagnostic contract manufacturing market because of the improvement of healthcare facilities and the increasing presence of many target groups in this region.

Recent Developments: 

  • In May 2020, Celestica's Newmarket Operation has successfully obtained a contract with StarFish Medical Inc. to manufacture ventilators specifically for the Canadian market. StarFish Medical selected Celestica due to its vast expertise in design, supply chain management, ISO 13485 certified production, and dedication to upholding the most stringent quality and regulatory requirements.
  • In May 2020, Sanmina Corporation has successfully obtained the Medical Device Single Audit Program certification for its operations in Malaysia, Singapore, and Sweden. The MDSAP accreditation allows for a single audit of the three manufacturing facilities by a recognized third party, ensuring compliance with laws for medical device markets in Australia, Brazil, Canada, Japan, and the US.

Diagnostic Contract Manufacturing Market Report Scope

Report Attribute

Specifications

Market Size Value In 2023

USD 25.7 Bn

Revenue Forecast In 2031

USD 57.9 Bn

Growth Rate CAGR

CAGR of 10.78% from 2024 to 2031

Quantitative Units

Representation of revenue in US$ Million and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report Coverage

The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends

Segments Covered

By Device, Services, And Application

Regional Scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country Scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; France; Italy; Spain; Southeast Asia; South Korea

Competitive Landscape

Jabil Inc., Flex Ltd., Plexus Corp, Sanmina Corporation, TE Connectivity Ltd., Celestica Inc., Integer Holdings Corporation, Nipro Medical Corporation, Thermo Fisher Scientific, West Pharmaceutical Services, Inc., Benchmark Electronics Inc., Kimball Electronics Inc., KMC Systems Savyon Diagnostics, Nova Biomedical, Cenogenic Corporation, Cone Bioproducts, Avioq Inc., Philips-Medisize Corporation, Invetech, Meridian Bioscience, Inc., Nolato AB, Fujirebio, Sekisui Prestige Diagnostics, Biokit, Other Market Players

Customization Scope

Free customization report with the procurement of the report and modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing And Available Payment Methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope

1.1. Research Methodology

1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Diagnostic Contract Manufacturing Market Snapshot

Chapter 4. Global Diagnostic Contract Manufacturing Market Variables, Trends & Scope

4.1. Market Segmentation & Scope

4.2. Drivers

4.3. Challenges

4.4. Trends

4.5. Investment and Funding Analysis

4.6. Industry Analysis – Porter’s Five Forces Analysis

4.7. Competitive Landscape & Market Share Analysis

4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Product Estimates & Trend Analysis

5.1. by Product & Market Share, 2019 & 2031

5.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Product:

5.2.1. In Vitro Diagnostic Devices

5.2.1.1. IVD Consumables

5.2.1.2. IVD Equipment

5.2.2. Diagnostic Imaging Devices

5.2.2.1. CT

5.2.2.2. X-ray

5.2.2.3. Ultrasound

5.2.2.4. MRI

5.2.2.5. Others

5.2.3. Other Devices

Chapter 6. Market Segmentation 2: by Service Estimates & Trend Analysis

6.1. by Service & Market Share, 2019 & 2031

6.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Service:

6.2.1. Device Development and Manufacturing Services

6.2.2. Quality Management Services

6.2.3. Packaging and Assembly Services

6.2.4. Other Services

Chapter 7. Market Segmentation 3: by Application Estimates & Trend Analysis

7.1. by Application & Market Share, 2019 & 2031

7.2. Market Size (Value (US$ Mn)) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:

7.2.1. In Vitro Diagnostic Devices

7.2.1.1. Infectious Diseases

7.2.1.2. Diabetes

7.2.1.3. Oncology

7.2.1.4. Cardiology

7.2.1.5. Other Applications

7.2.2. Diagnostic Imaging Device

7.2.2.1. Cardiology

7.2.2.2. Oncology

7.2.2.3. Orthopedics

7.2.2.4. Neurology

7.2.2.5. Other Applications

7.2.3. Other Devices

7.2.3.1. Gastroenterology

7.2.3.2. Gynecology

7.2.3.3. Other Application

Chapter 8. Diagnostic Contract Manufacturing Market Segmentation 4: Regional Estimates & Trend Analysis

8.1. North America

8.1.1. North America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031

8.1.2. North America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2019-2031

8.1.3. North America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031

8.1.4. North America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

8.2. Europe

8.2.1. Europe Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031

8.2.2. Europe Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2019-2031

8.2.3. Europe Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031

8.2.4. Europe Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

8.3. Asia Pacific

8.3.1. Asia Pacific Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031

8.3.2. Asia Pacific Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2019-2031

8.3.3. Asia-Pacific Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031

8.3.4. Asia Pacific Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

8.4. Latin America

8.4.1. Latin America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031

8.4.2. Latin America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2019-2031

8.4.3. Latin America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031

8.4.4. Latin America Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

8.5. Middle East & Africa

8.5.1. Middle East & Africa Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Product, 2019-2031

8.5.2. Middle East & Africa Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Service, 2019-2031

8.5.3. Middle East & Africa Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by Application, 2019-2031

8.5.4. Middle East & Africa Diagnostic Contract Manufacturing Market Revenue (US$ Million) Estimates and Forecasts by country, 2019-2031

Chapter 9. Competitive Landscape

9.1. Major Mergers and Acquisitions/Strategic Alliances

9.2. Company Profiles

9.2.1. Jabil Inc.

9.2.2. Flex Ltd.

9.2.3. Plexus Corp

9.2.4. Sanmina Corporation

9.2.5. TE Connectivity Ltd.

9.2.6. Celestica Inc.

9.2.7. Integer Holdings Corporation

9.2.8. Nipro Medical Corporation

9.2.9. Thermo Fisher Scientific

9.2.10. West Pharmaceutical Services, Inc.

9.2.11. Benchmark Electronics Inc.

9.2.12. Kimball Electronics Inc.

9.2.13. KMC Systems

9.2.14. Savyon Diagnostics

9.2.15. Nova Biomedical

9.2.16. Cenogenic Corporation

9.2.17. Cone Bioproducts

9.2.18. Avioq Inc.

9.2.19. Philips-Medisize Corporation

9.2.20. Invetech

9.2.21. Meridian Bioscience, Inc.

9.2.22. Nolato AB

9.2.23. Fujirebio

9.2.24. Sekisui

9.2.25. Prestige Diagnostics

9.2.26. Biokit

9.2.27. Other Market Players

Segmentation of Diagnostic Contract Manufacturing Market-

Diagnostic Contract Manufacturing Market By Device-

  • In Vitro Diagnostic Devices
    • IVD Consumables
    • IVD Equipment
  • Diagnostic Imaging Devices
    • X-ray
    • CT scan
    • Ultrasound
    • MRI
    • Others
  • Other Devices

Diagnostic Contract Manufacturing Market seg

Diagnostic Contract Manufacturing Market By Service-

  • Device Development & Manufacturing
  • Quality Management
  • Packaging & Assembly

Diagnostic Contract Manufacturing Market By Application-

  • In Vitro Diagnostic Devices
    • Infectious Diseases
    • Diabetes
    • Oncology
    • Cardiology
    • Others
  • Diagnostic Imaging Devices
    • Cardiology
    • Neurology
    • Orthopedics
    • Oncology
    • Others
  • Other Devices
    • Gastroenterology
    • Gynecology
    • Others

Diagnostic Contract Manufacturing Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of the Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Diagnostic Contract Manufacturing Market Size?

Diagnostic Contract Manufacturing Market is expected to grow at a 10.78% CAGR during the forecast period for 2024-2031.

Cone Bioproducts, Avioq Inc., Philips-Medisize Corporation, Invetech, Meridian Bioscience, Inc., Nolato AB, Fujirebio, Sekisui Prestige Diagnostics, B

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Medical Devices

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach